Stockreport

Axcelead DDP Enters into Drug Discovery Service Agreement with Astellas for Targeted Protein Degraders [Yahoo! Finance]

ASTELLAS PHARMA UNSP/ADR  (ALPMY) 
NASDAQ:AMEX Investor Relations: astellas.com/jp/en/investors
PDF that it has entered into a drug discovery service agreement with Astellas Pharma, Inc. (HQ: Chuo-Ku, Tokyo, Japan; "Astellas") to explore new candidate compounds for tar [Read more]